Literature DB >> 26840500

Preventing Infections in Sickle Cell Disease: The Unfinished Business.

Stephen K Obaro1,2,3,4, P Y Iroh Tam5.   

Abstract

While encapsulated bacterial agents, particularly Streptococcus pneumoniae, are recognized as important microbes that are associated with serious illness in hosts with sickle cell disease (SCD), multiple pathogens are implicated in infectious manifestations of SCD. Variations in clinical practice have been an obstacle to the universal implementation of infection preventive management through active, targeted vaccination of these individuals and routine usage of antibiotic prophylaxis. Paradoxically, in low-income settings, there is evidence that SCD also increases the risk for several other infections that warrant additional infection preventive measures. The infection preventive care among patients with SCD in developed countries does not easily translate to the adoption of these recommendations globally, which must take into account the local epidemiology of infections, available vaccines and population-specific vaccine efficacy, environment, health care behaviors, and cultural beliefs, as these are all factors that play a complex role in the manifestation of SCD and the prevention of infectious disease morbidity.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  encapsulated bacteria; malaria; sickle cell; vaccination

Mesh:

Substances:

Year:  2016        PMID: 26840500     DOI: 10.1002/pbc.25911

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  9 in total

1.  Paper-based microchip electrophoresis for point-of-care hemoglobin testing.

Authors:  Muhammad Noman Hasan; Arwa Fraiwan; Ran An; Yunus Alapan; Ryan Ung; Asya Akkus; Julia Z Xu; Amy J Rezac; Nicholas J Kocmich; Melissa S Creary; Tolulope Oginni; Grace Mfon Olanipekun; Fatimah Hassan-Hanga; Binta W Jibir; Safiya Gambo; Anil K Verma; Praveen K Bharti; Suchada Riolueang; Takdanai Ngimhung; Thidarat Suksangpleng; Priyaleela Thota; Greg Werner; Rajasubramaniam Shanmugam; Aparup Das; Vip Viprakasit; Connie M Piccone; Jane A Little; Stephen K Obaro; Umut A Gurkan
Journal:  Analyst       Date:  2020-03-03       Impact factor: 4.616

2.  Homozygous sickle cell disease related mortality in Senegal (2011-2020).

Authors:  Moussa Seck; Oumou Ba; Blaise Felix Faye; Sokhna Aissatou Touré; Youssou Bamar Guèye; Nata Dieng; Abibatou Sall; Macoura Gadji; Awa Oumar Touré; Saliou Diop
Journal:  EJHaem       Date:  2021-10-04

3.  Fever Management in Sickle Cell Disease in Low- and Middle-Income Countries: A Survey of SCD Management Programs.

Authors:  Alexandra L Coria; Catherine M Taylor; Venée N Tubman
Journal:  Am J Trop Med Hyg       Date:  2020-04       Impact factor: 2.345

4.  The gut microbiome in sickle cell disease: Characterization and potential implications.

Authors:  Hassan Brim; James Taylor; Muneer Abbas; Kimberly Vilmenay; Mohammad Daremipouran; Sudhir Varma; Edward Lee; Betty Pace; Waogwende L Song-Naba; Kalpna Gupta; Sergei Nekhai; Patricia O'Neil; Hassan Ashktorab
Journal:  PLoS One       Date:  2021-08-25       Impact factor: 3.240

5.  Mantle Cell Hyperplasia of Peripheral Lymph Nodes as Initial Manifestation of Sickle Cell Disease.

Authors:  Ahmad Monabbati; Sadat Noori; Akbar Safaei; Mani Ramzi; Seyedsajjad Eghbali; Ali Adib
Journal:  Case Rep Hematol       Date:  2016-10-30

6.  Vascular Permeability Drives Susceptibility to Influenza Infection in a Murine Model of Sickle Cell Disease.

Authors:  Erik A Karlsson; Thomas H Oguin; Victoria Meliopoulos; Amy Iverson; Alexandria Broadnax; Sun-Woo Yoon; Tamara Pestina; Paul Thomas; Richard Webby; Stacey Schultz-Cherry; Jason W Rosch
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

7.  Invasive bacterial infections in Gambians with sickle cell anemia in an era of widespread pneumococcal and hemophilus influenzae type b vaccination.

Authors:  Germander Soothill; Saffiatou Darboe; Gibril Bah; Lawal Bolarinde; Aubrey Cunnington; Suzanne T Anderson
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

Review 8.  Life-Threatening Infectious Complications in Sickle Cell Disease: A Concise Narrative Review.

Authors:  Dominik Ochocinski; Mansi Dalal; L Vandy Black; Silvana Carr; Judy Lew; Kevin Sullivan; Niranjan Kissoon
Journal:  Front Pediatr       Date:  2020-02-20       Impact factor: 3.418

9.  A retrospective case study of successful translational research: Gazelle Hb variant point-of-care diagnostic device for sickle cell disease.

Authors:  Kelli Qua; Shannon M Swiatkowski; Umut A Gurkan; Clara M Pelfrey
Journal:  J Clin Transl Sci       Date:  2021-10-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.